Stanford University – Legal and illegal drugs are killing more people than AIDS ever did, yet the nation’s drug policies are based on unproven assumptions about addiction. Neuroscience could help shape more effective policies and save lives.
Huffington Post – After weeks of closed door meetings, Republicans unveiled a discussion draft of the Senate’s health care replacement bill on Thursday. Should the bill pass in its current form, funding for opioid and addiction treatment would plummet.
The New York Times – The Department of Homeland Security, working with Google, introduced a $1.5 million contest to build computer algorithms that can automatically identify concealed items in images captured by checkpoint body scanners.
Austin American-Statesman – Texas Attorney General Ken Paxton can proceed with an appeal seeking to resurrect a state rule that requires fetal tissue to be buried or cremated, a federal appeals court has ruled.
The Hill – Sen. Roy Blunt (R-Mo.), the chairman of the Senate’s health appropriations subcommittee, on Thursday tore into the Trump administration’s proposal to cut National Institutes of Health (NIH) funding by $7.5 billion.
Regulatory Affairs Professionals Society – Although the US market is likely more than a year or two away from seeing any commercialized medical products that rely on CRISPR-Cas9 technology, the rapidly developing field has grabbed the attention of the FDA.
The Washington Post – Soon after graduating high school, Lauren Seitz joined herWesterville, Ohio, youth music ministry group to sing at churches and nursing homes. The eight-day trip included a white-water rafting experience in North Carolina that would prove deadly.
Science – Congress will consider thousands of pieces of legislation this year, most doomed to failure. Indeed, only about 4% of these bills become law. So which ones are worth paying attention to? A new artificial intelligence algorithm could help.
The New York Times / Reuters – Missouri on Wednesday became the third U.S. state to accuse major drug manufacturers of fraudulently misrepresenting the risks of opioid painkillers now at the center of a national addiction epidemic.